Asia Pacific Drug Addiction Treatment Market Report

Asia Pacific Drug Addiction Treatment Market Report, by Drug Type (Tobacco/Nicotine and Vaping, Alcohol, Marijuana, Synthetic Cannabinoids, Over The Counter Medications), Treatment (Detoxication, Counselling and Behavioural Therapies, Rehabilitation Programs, Self Help Groups, Medicines), End User (Hospitals, Homecare, Speciality Clinics) and Country - Asia Pacific Market Share, Trend, Analysis & Forecast , 2021 - 2031

Report Code : 10721 | Publish Date : Upcoming | Industry : Healthcare | Geography : APAC


Drug addiction is described as chronic, degenerating disorder. Like all chronic conditions, long-time efforts must be applied for the person for restraining drug consumption. No one would expect increase blood sugar level with diabetic patient it should remain in normal ranges with prescribed care regimens after one month after meeting with physician. Likewise, if drug addict only applies the principle of treatment for limited time periods, continuation of addictive behaviour is expected in that case. One of the treatments for prevention of recontinuation of addiction is to extend treatment as long as possible. Additionally, suggesting relapse preventions which may helpful during drug addiction treatment. Some of the common parts of relapse preventions are identification of high-risk scenarios, development and practise of skills for effective management of high-risk situations, increasing self-confidence and learn to slip away from drug abuse than recontinuing drug abuse. 

Market Dynamics - Asia Pacific Drug Addiction Treatment Market 

The Asia Pacific drug addiction treatment market is anticipated to witness lucrative growth during forecast period 2021-2027. The rising number of alcohol and other drug consumption is gaining the market attention of Asia Pacific drug addiction treatment market. The dynamic factors like higher treatment seeking rate is propelling the market growth. Rise in patient awareness programs is also refuelling the market growth. Adoption of unhealthy lifestyles can increase risk of substance abuse is also elevating the market growth. However, patent expiration and launch of generic version of drugs is hampering the market growth. 

COVID-19 Impact on Asia Pacific Drug Addiction Treatment Market

The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the drug addiction treatment market. In addition, complete analysis of changes on drug addiction treatment expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Asia Pacific economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The drug addiction increases the risk of COVID-19. The tobacco/nicotine, marijuana, heroin or cocaine have shown unhealthier lung conditions like chronic obstructive pulmonary diseases, asthma and chronic lung diseases may rises risk of severe illness from COVID-19. The use of stimulants such as methamphetamine, cocaine rises risk of stroke, heart attack, abnormal heart rhythm, seizures along with other conditions that may lead to more severe lung damage to the patient affected by COVID-19 as because of that drug addiction treatment market is witnessing positive impact on the drug addiction treatment market. 


Asia Pacific Drug Addiction Treatment Market - Segmental Overview 

The Asia Pacific drug addiction treatment market is bifurcated by drug type, treatment, end user and country.

Asia Pacific Drug Addiction Treatment Market by Drug Type 

The different drug types like tobacco/ nicotine and vaping, alcohol, marijuana, synthetic cannabinoids and over the counter medications are comprised in Asia Pacific drug addiction treatment market. In which synthetic cannabinoids is also contributing in the market growth of drug addiction treatment market. Synthetic cannabinoids were chiefly hypothesised as a critical pharmacological tool for evaluation of endocannabinoid systems. The main objective of synthetic cannabinoids is to use in pain management, neurological disorder treatment. But it has impact on mood and impairment of executive functions. They are human made mind altering chemical which is either sprayed on dry, shredded plant material so they can smoke or sold as liquid to be vaporized and inhaled in e-cigarettes and other devices. 

Asia Pacific Drug Addiction Treatment Market by Treatment 

The various treatment types like detoxification, counselling and behavioural therapies, rehabilitation program, self-help groups and medications are comprised in Asia Pacific drug addiction treatment market. In which medication is also contributing in the market growth of Asia Pacific drug addiction treatment market. The medicines like Naltrexone, Acamprosate, Methadone, Buprenorphine and other are used for deaddiction of patients. The medication plays a significant role in deaddiction of person. The rising cases of alcohol consumption and social acceptance of alcohol consumption is driving the market growth of Asia Pacific drug addiction treatment market. 

Asia Pacific Drug Addiction Treatment Market by End User 

The variety of end users like hospitals, homecare, speciality clinics and other are comprised in the Asia Pacific drug addiction treatment market. In which hospitals is expected to dominate the market in 2020. The need for hospitalization in severe addiction is propelling the growth of segment. The rising funding by government for treatment of drug addicts is also refuelling the growth of segment. The increasing population prone to addiction is also boosting the market growth of Asia Pacific drug addiction treatment market. 

Asia Pacific Drug Addiction Treatment Market by Country 

The Asia Pacific drug addiction treatment market is studied for countries like India, Japan, China, South Korea and Australia. In which China and Japan is anticipated to dominate the region in 2020. The rising awareness about drug addiction side effects is propelling the market growth. The rise in new smokers and drinkers is also refuelling the growth of region. The rising initiative by government for management of drug addiction is also elevating the market growth of Asia Pacific drug addiction treatment market. 

Key Players in Drug Addiction Treatment Market 

The major key players like Hager Biosciences Llc, Addex Therapeutics, Omeros Corporation, Sosei Group Corporation, Cv Sciences Inc, Cerecor Inc, Astraea Therapeutics Llc, Johnson & Johnson Services Inc., Glaxosmithkline Plc, Pfizer Inc, Novartis Ag, Sanofi, Dr. Reddy’S Laboratories Ltd, Teva Pharmaceutical Industries Ltd, Mylan N.V., Axsome Therapeutics Inc, H. Lundbeck A/S, Zydus Cadila and Glenmark Pharmaceuticals Ltd among other are analysed in the market.

Key Developments in Drug Addiction Treatment Market

November 2018: Sandoz collaborated with pear therapeutic and announced launching of reSET® for management of patients with substance abuse disorder. It is only discovered drug approved by FDA-authorized prescription digital therapeutic for treatment of conditions. 

October 2017: Maryland addiction recovery centre of towson and carcon treatment centres announced their new collaboration along the enterprises and handover of encore recovery solutions which is located in Arlington, Virginia. 

June 2017: Pfizer collaborated with Eli Lily and co. for development of non-opioid chronic pain medication called tanezumab. The collaboration got the fast-track approval by Food and Drug administration for treatment of chronic back pain and osteoarthritis.

The study comprised of drug addiction treatment market. In which study analysed the various segments of the market. The drug addiction treatment market is bifurcated by drug type, treatment and end users. The study also comprised of dominating segment of the market. The drug type segment is dominated by alcohol. Likewise, treatment segment is dominated by self-help groups and end user is dominated by hospitals. The study also imparts the geographical section of the market and it concludes that China and Japan is anticipated to dominate the market in 2020. The study comprised of impact of COVID-19 on drug addiction treatment market and it is profounds that drug addiction increases the risk of COVID-19. The tobacco/nicotine, marijuana, heroin or cocaine have shown unhealthier lung conditions like chronic obstructive pulmonary diseases, asthma and chronic lung diseases may rises risk of severe illness from COVID-19. The use of stimulants such as methamphetamine, cocaine rises risk of stroke, heart attack, abnormal heart rhythm, seizures along with other conditions that may lead to more severe lung damage to the patient affected by COVID-19 as because of that drug addiction treatment market is witnessing positive impact on the drug addiction treatment market. The study also imparts major key players operating in the market. 

Why to buy this report 

  • The report offers changing market dynamics in the drug addiction treatment markets industry, presenting historical, current and projected market size in terms of value (USD Million)
  • The research study provides an in-depth analysis of the industry value chain focusing on the peer and parent markets of the drug addiction treatment market
  • It presents a comprehensive assessment of countries exhibiting promising growth, potential and niche segments and a neutral perspective of the drug addiction treatment market
  • The report also offers strategic recommendations in key business segments based on the market estimations and competitive landscape, mapping the key common trends of drug addiction treatment market